[Latest] Global Pharmaceutical Waste Management Market Size/Share Worth USD 65.6 Billion by 2033 at a 7.8% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
May 23, 2024 12:30 ET
|
Custom Market Insights
Austin, TX, USA, May 23, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Pharmaceutical Waste Management Market Size, Trends and Insights By Type...
SOHM, Inc., Targets Revolutionary New ABBIE Genome Editing Kits for Q3, 2024
May 22, 2024 12:57 ET
|
SOHM, Inc.
CHINO HILLS, Calif., May 22, 2024 (GLOBE NEWSWIRE) -- via IBN -- SOHM, Inc. (OTC PINK: SHMN)– a leading generic pharmaceutical and upstart biotechnology company, is proud to announce its ongoing...
PRISM MarketView Highlights Soligenix, Inc. as it Builds on Compelling Phase 3 Data with Key Catalysts on the Horizon
May 21, 2024 12:35 ET
|
PRISM MarketView
PRISM MarketView Highlights Soligenix, Inc. as it Builds on Compelling Phase 3 Data with Key Catalysts on the Horizon
Following Guidance from U.S. Food & Drug Administration in Type-C Meeting Lipella Pharmaceuticals to Advance Lead Product Candidate to Phase 2b
May 21, 2024 08:00 ET
|
Lipella Pharmaceuticals Inc.
Following Guidance from U.S. Food & Drug Administration in Type-C Meeting Lipella Pharmaceuticals to Advance Lead Product Candidate to Phase 2b
SAB Biotherapeutics Announces Q1 2024 Financial Results and Provides Company Updates
May 20, 2024 17:45 ET
|
SAB Biotherapeutics, Inc.
SAB Biotherapeutics Announces Q1 2024 Financial Results
Entera Bio Appoints Dr. Rachel B Wagman as Key Clinical Advisor and Scientific Advisory Board Member
May 15, 2024 08:00 ET
|
Entera Bio Ltd.
JERUSALEM, May 15, 2024 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”), a leader in the development of orally delivered peptides and small therapeutic proteins,...
ADC Therapeutics to Participate in 2024 RBC Capital Markets Global Healthcare Conference
May 09, 2024 07:15 ET
|
ADC Therapeutics SA
LAUSANNE, Switzerland, May 09, 2024 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT) today announced that Ameet Mallik, Chief Executive Officer, will participate in a fireside chat at the 2024...
Flexible Packaging Market Surges to USD 292.08 Billion by 2031, Propelled by 4.89% CAGR - Verified Market Research®
May 07, 2024 10:15 ET
|
Verified Market Research
Lewes, Delaware, May 07, 2024 (GLOBE NEWSWIRE) -- The Global Flexible Packaging Market is projected to grow at a CAGR of 4.89% from 2024 to 2031, according to a new report published by Verified...
PRISM MarketView Spotlights Oncocyte Corporation as it Works to Disrupt the Precision Diagnostics Marketplace
May 07, 2024 09:19 ET
|
PRISM MarketView
PRISM MarketView Spotlights Oncocyte Corporation as it Works to Disrupt the Precision Diagnostics Marketplace
Madrigal Pharmaceuticals Reports First-Quarter 2024 Financial Results and Provides Corporate Updates
May 07, 2024 07:00 ET
|
Madrigal Pharmaceuticals, Inc.
On March 14, 2024, received U.S. FDA approval of Rezdiffra™ (resmetirom) for the treatment of patients with noncirrhotic nonalcoholic steatohepatitis (NASH) with moderate to advanced liver fibrosisIn...